Interestingly, Anti-DPP4 autoantibodies have been observed in RA patients and may be used as a biomarker for early diagnosis of RA (108), which suggests that DPP4 may contributes to the immunopathology of RA. Here, DPP4 is linked to rheumatoid arthritis.